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ABSTRACT
Protein aggregates are the pathogenic hallmarks of many different
neurodegenerative diseases and include the accumulation of
α-synuclein, the main component of Lewy bodies found in
Parkinson’s disease. Aggresomes are closely-related, cellular
accumulations of misfolded proteins. They develop in a
juxtanuclear position, adjacent to the centrosome, the microtubule
organizing centre of the cell, and share some protein components.
Despite the long-standing observation that aggresomes/Lewy bodies
and the centrosome sit side-by-side in the cell, no studies have been
done to see whether these protein accumulations impede organelle
function. We investigated whether the formation of aggresomes
affected key centrosome functions: its ability to organise the
microtubule network and to promote cilia formation. We find that
when aggresomes are present, neuronal cells are unable to organise
their microtubule network. New microtubules are not nucleated and
extended, and the cells fail to respond to polarity cues. Since neurons
are polarised, ensuring correct localisation of organelles and the
effective intracellular transport of neurotransmitter vesicles, loss of
centrosome activity could contribute to functional deficits and
neuronal cell death in Parkinson’s disease. In addition, we provide
evidence that many cell types, including dopaminergic neurons,
cannot form cilia when aggresomes are present, which would affect
their ability to receive extracellular signals.
KEY WORDS: Parkinson’s disease, Centrosome, Aggresome, Cilia,
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INTRODUCTION
Parkinson’s disease (PD) is a progressive neurodegenerative
condition that affects 1 in 500 of the population (Schrag et al.,
2000; Alves et al., 2008). Dopaminergic neurons in the substantia
nigra pars compacta are first affected (Alves et al., 2008). As the
disease progresses, other parts of the brain and nervous system are
affected, with dementia occurring in later stages. Within neurons of
PD patients, large α-synuclein-positive intracellular inclusions
known as Lewy bodies are observed (Wakabayashi et al., 2012).
Increased α-synuclein (α-syn) levels, which occur in rare cases with
multiplication of the SNCA gene, are sufficient to cause PD
(Singleton et al., 2003; Ibanez et al., 2004) and mutations associated
with SNCA lead to an increase in aggregation propensity (Conway
et al., 1998; Polymeropoulos et al., 1997; Kruger et al., 1998). These
mutations cause α-syn to form oligomers, fibrils then aggregates.
Large aggregates of α-syn constitute the Lewy bodies frequently
found in the neurons of PD patients (Baba et al., 1998; Spillantini
et al., 1997). It is unclear if these aggregates or Lewy bodies protect
the cell from smaller unfolded units of α-syn or if these structures
are pathogenic and ultimately contribute to neuronal death.
Lewy bodies are observed in several diseases [PD, dementia with
Lewy bodies, incidental Lewy body disease (Wakabayashi et al.,
2012)] but are not found in healthy cells and they are related to the
aggresome, a structure found in cells that are processing large
amounts of waste, unfolded polypeptide (Johnston et al., 1998). The
aggresome is a juxtanuclear inclusion body containing heat-shock
proteins and components of the ubiquitin-proteasome system
(Olzmann et al., 2008). These components are also found within
Lewy bodies and they share ultrastructural similarities. This has led
to the proposal that Lewy bodies are derived from aggresomes to
specifically deal with misfolded α-syn (McNaught et al., 2002;
Olanow et al., 2004).
The juxtanuclear location of the aggresome is shared by the
centrosome, the microtubule organising centre of the cell. Indeed,
they sit side-by-side and centrosomal markers such as γ-tubulin are
often used to detect the aggresome, alongside the intermediate
filaments such as vimentin that cage the structure (McNaught et al.,
2002). While the position of the aggresome at the centre of the
microtubule network has logic in terms of transporting unfolded
protein to a central location to be further processed, it may affect the
function of the centrosome, whose major role is to organise this part
of the cytoskeleton. Steric hindrance on a macromolecular scale
may perturb centrosome function. Furthermore, the centrosome is
used to make the cilium. This hair-like structure on the surface of
cells has important roles both in motility, inter-cellular
communication and monitoring the external environment, with
specialised cilia housing photopigments and olfactory receptors
(Nigg and Raff, 2009; Ibanez-Tallon et al., 2003). To make the
cilium, the centrioles of the centrosome migrate to the cell surface, a
process that could be blocked by a large aggregate of protein
smothering the centrosome or sticking it to the nucleus.
The colocalization of the aggresome and centrosome and the
sharing of protein components has been known for nearly 20 years.
Generating aggresomes by proteasome inhibition via MG132
treatment inhibits microtubule-based transport of lysosomes and
mitochondria near to the centrosome generating an ‘entrapment
zone’ (Zaarur et al., 2014). Furthermore, such aggresomes perturb
microtubule nucleation by the centrosome and disrupt transport of
the dopamine transporter in a neuronal cell line (Diaz-Corrales et al.,
2012). However, the disease relevance of these aggresomes isReceived 12 June 2020; Accepted 25 August 2020
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unclear and the effect of α-syn-positive aggresomes on the function
of the centrosome has not been investigated. This could have
important implications for the aetiology of PD and other
neurodegenerative diseases in which such aggregates are formed.
In this study we sought to test whether multiple functions of the
centrosome were impeded by the presence of α-syn-positive
aggresomes in their close vicinity using both in vitro and in vivo
models. Our results suggest that inhibition of centrosome function
might contribute to loss of function in neurons where there is
aggregation of α-syn.
RESULTS
Aggresomes localise in close proximity to the centrosome
We sought to make aggresomes in the cells on which we performed
subsequent experiments by two parallel means (Tanaka et al., 2004;
Winslow et al., 2010). Cells were transfected with expression
constructs encoding GFP fusions of human α-syn or mutant
versions, A30P and A53T, found in familial cases of Parkinson’s
(Kruger et al., 1998; Polymeropoulos et al., 1997) or treated with
MG132, a proteasome inhibitor. Our primary aim was to investigate
the effect of α-syn-positive aggresomes on centrosome function and
compare this to aggresomes generated via proteasome inhibition.
The presence of aggresomes was then confirmed by staining with
established markers for aggresomes: anti-vimentin or anti-γ-tubulin
antibodies (Johnston et al., 1998; Olanow et al., 2004; Wigley et al.,
1999). HeLa cells and SH-SY5Y cells, a neuroblastoma line,
showed a dense zone of vimentin staining next to the nucleus, which
was absent in untreated cells, whether α-syn transfection – native or
mutant forms of the protein associated with familial use PD – or
MG132 treatment was used to generate the aggresomes (Fig. 1A–J).
Similar results were obtained with γ-tubulin staining, with a dense
area of γ-tubulin staining instead of the usual two punctae
representing the centrosome (Fig. 1K,L). Importantly, accumulation
of endogenous α-syn was observed in aggresomes induced byMG132,
demonstrating that both methods resulted in the accumulation of
disease-associated, aggregate-prone proteins (Fig. 1M–P). It was
notable that in treated cells, the centrosomes were frequently very
difficult to detect by γ-tubulin alone, with the aggresomal gamma
tubulin signal seemingly smothering that from the region around the
centrioles.
SH-SY5Y cells can be differentiated into dopaminergic neurons
if treated with retinoic acid. Since dopaminergic neurons are the
first neurons to be affected in PD, we repeated the above
experiment with differentiated SH-SY5Y cells and rat basal
ganglion neurons using the MG132 induction method since the
poor transfection efficiency in these precludes the use of α-syn
constructs (Fig. 1Q–X). Differentiation was confirmed by staining
for tyrosine hydroxylase (anti-TH1 antibody in green).
Aggresomes could also be generated both types of cell when
they were treated with MG132, as assayed by vimentin staining
(Fig. 1Q,R,U,V) and γ-tubulin staining (Fig. 1S,T,W,X). Similarly,
aggresomes were generated in immortalised human retinal pigment
epithelial (RPE1-hTERT) cells and mouse embryonic fibroblast
(MEFs) cells, which were used in subsequent experiments alongside
SH-SY5Y cells (Fig. 1Y-β).
Aggresomes suppress microtubule nucleation
The major function of the centrosome in interphase cells is the
nucleation and organisation of the microtubule network (Bornens,
2002). The ability of the centrosome to nucleate microtubules can
be assayed by the microtubule regrowth assay, in which the
microtubules are first depolymerised by cold treatment for 30 min
(Fig. 2Ai,ii) followed by warming of the cells so that the
centrosome can nucleate a new network (Fig. 2Aiii, iv) (De
Brabander et al., 1986; Fry et al., 1998). In control, untreated
SH-SY5Y cells, the microtubules were nucleated after 30 s of
warming following depolymerisation, with a clear aster of
α-tubulin staining and an extensive network after 10 min
(Fig. 2Ai–iv). For SH-SY5Y cells transfected with expression
constructs for GFP-tagged α-syn, only 23±3.5% of the cells
initiated microtubule nucleation by 10 min, whereas 72±3.8%
of cells transfected with a control GFP expression plasmid
re-established their network within the same time (Fig. 2Av–viii,
B; Fig. S1). Cells transfected with α-syn with familial A30P or
A53T mutations also failed to regrow their network within 10 min
(Fig. 2Aix–xvi; Fig S1). Generating aggresomes via a second,
independent route, gave the same result: cells treated with MG132
for 24 h prior to the assay did not nucleate any microtubules after
10 min warming (Fig. 2Axvii–xx), with only 5.3±0.58% of
treated cells starting nucleation but 84±5.0% of untreated cells
making an aster (Fig. 2B).
Due to the morphology of the cell and the number of stabilized
microtubules, the network and reforming aster is more difficult to
observe in differentiated SH-SY5Y cells than in continuously
growing cell lines. Nevertheless, when aggresome formation was
induced by MG132 treatment 21±6.7% of treated cells were able to
make an aster, whereas 78±4.2% of untreated cells re-establish their
labile microtubule network (Fig. 2Axxi–xxvii,B).
Aggresomes prevent cell migration
In healthy cells, the microtubule network is remodelled in response
to polarity cues. This function of the centrosome can be tested by the
wound assay. A strip of cells is removed from a confluent culture
and those at the border of this wound will migrate to close the gap
(Nobes and Hall, 1999). The Golgi and centrosome re-orientate to
face the direction of cell locomotion. RPE1-hTERT cells and MEFs
migrate and close a ‘wound’ in 12 h (Fig. 3A–D,I–L). In the
presence of aggresomes generated by MG132 treatment, migration
was halted with no cell movement to close the gap (Fig. 3E–H,M–P).
Time-lapse observations of treated and untreated cells
(Supplementary Movies 1–4) clearly demonstrate this lack of
migration. 25% of the wound was closed in treated cells versus
near-complete wound closure for untreated cells. The Golgi also did
not re-orientate: control RPE1-hTERT cells’ Golgi re-orientated to
face the wound (Fig. 3Q versus R), whereas in treated cells the Golgi
remained randomly orientated (Fig. 3S versus T). If we measure the
angle of the Golgi relative to a line perpendicular the wound, then
control cells at 5 h face the wound (average of 44.2° displacement
from perpendicular, where 45° displacement from perpendicular
represents ‘perfect’ alignment) whereas treated cells at 5 h have a
random orientation of the Golgi (average of 66.7° displacement from
perpendicular) (Fig. 3U,V).
Aggresome formation inhibits ciliogenesis
We next tested if the presence of aggresomes prevents cells from
making cilia as ciliogenesis requires the centrioles of the
centrosome to move to the cell surface where one centriole
templates the axoneme that forms the internal structure of the
cilium. Many cell types ciliate, but not all. We tested several cell
types for the presence of cilia by staining for acetylated tubulin
together with γ-tubulin to mark the basal bodies. Undifferentiated
SH-SY5Y cells generated cilia when serum starved and GFP
over-expression (control plasmid) did not affect ciliogenesis
(Fig. 4A,E,K). Undifferentiated SH-SY5Y cells failed to ciliate
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whenGFP-α-syn (Fig. 4B) was overexpressed. Familial mutant forms
of GFP-α-syn –A30PandA53T – had the same effect (Fig. 4C,D,K).
MG132 treatment also reduced ciliogenesis (Fig. 4F,K).
Differentiated SH-SY5Y cells formed cilia (Fig. 4G) but did not
do so when treated with MG132 (Fig. 4H,K). Rat basal ganglion
cells are ciliated under their normal culture conditions (Fig. 4I) but
their ciliogenesis was much reduced when treated with MG132
(Fig. 4J; Fig. S2).
To test whether aggresome formation affected ciliogenesis in an
in vivo system, we performed α-syn over-expression experiments in
Fig. 1. See next page for legend.
3
RESEARCH ARTICLE Biology Open (2020) 9, bio054338. doi:10.1242/bio.054338
B
io
lo
g
y
O
p
en
zebrafish embryos. The ciliated cells of the olfactory pit are
dopaminergic neurons, as indicated by tyrosine hydroxylase (TH)-
positive staining (Fig. 5A). We injected 1-cell embryos with in vitro
transcribed mRNA encoding human α-syn, (wild-type and familial
A30P and A53Tmutations) or GFP as a control (Fig. 5B–E). Larvae
were fixed at 2 days post-fertilisation (dpf) and assayed for olfactory
cilia by wholemount acetylated tubulin staining (Fig. 5F–I). Cilia
numbers were much reduced (11±3.6 versus 41±5.3 per pit) in the
olfactory zone when the embryos overexpressed GFP-α-syn (any
variant) compared to GFP alone (Fig. 5L). The remaining cilia were
reduced in length, by approximately 50% from 8.4±0.49 µm to 4.7±
0.71 µm (Fig. 5M). Treatment of embryos with MG132 caused loss
of cilia at 3 dpf (Fig. 5J, untreated; K, treated) with cilia number
being reduced from 65±11 per pit to 15±6 (Fig. 5L). Although we
did not attempt to image aggresomes in these embryos, the
difference between treated and untreated embryos, achieved by two
different methods, strongly suggests the effects are due to the
presence of aggresomes. The gross anatomy of these embryos was
otherwise normal (Fig. 5B–E). Absence of cilia may be expected to
cause other defects during embryogenesis, for example
hydrocephaly, left–right asymmetry defects and pronephric
cysts. We did not observe these defects. However, the effect on
ciliogenesis at the olfactory pits was mild at 24 hpf. We therefore
suspect that accumulation of α-syn is required over several days to
inhibit ciliogenesis hence earlier embryonic stages escape the
effects of aggresome-induced cilium loss. Similar loss of cilia was
observed when aggresomes were generated by an independent
method, MG132 treatment (Fig. 5J–L).
DISCUSSION
Aggresomes occupy a central position in the cell, at the hub of the
microtubule network, a location that places them in the vicinity of the
centrosome, the major microtubule organising centre of the cell.
Furthermore, the aggresome acquires an important centrosomal
component, γ-tubulin. We show here that α-syn accumulation is
sufficient to form aggresomes and these structures severely
compromise centrosome function. Microtubule nucleation is
severely reduced and the centrosome is unable to be repositioned
during the scratch-wound assay. These results are consistent with and
extend previous observations of the effect of MG132 on microtubule
nucleation (Didier et al., 2008; Diaz-Corrales et al., 2012). A simple,
steric hindrance of the centrosome is the simplest and most likely
explanation for this effect but it is also possible mislocalisation or
modification of specific centrosome proteins could also cause the
observed effects. For example, the accumulation of γ-tubulin at the
aggresome may sequester γ-tubulin molecules intended for the
centrosome. Importantly, we also observe these effects when
generating aggresomes by overexpressing α-syn. Indeed, MG132
treatment generates aggresomes in which endogenous α-syn is
accumulated. This suggests the effects are due to the aggresome itself
rather than inhibition of the proteasome and consequent modulation
of other pathways. Our data suggests that induction of aggresomes via
α-syn over-expression and via MG132 treatment produces
functionally equivalent aggresomes and these findings help to
unify the literature and observations made in previous studies using
only MG132 induction. It is important to note that reduction in
proteasome function is physiologically relevant in the context of
neurodegenerative disease. Indeed, deficits in the ubiquitin-
proteasome degradation system are well-established as causative
factors in ageing and neurodegenerative diseases (for review see
Rousseau and Bertolotti, 2018) and several recent studies have
demonstrated that GWAS-identified variants associated with a range
of neurodegenerative diseases cause deficits in proteasome function
(Lopez et al., 2017; Jabbari et al., 2018).
The centrosome is the main microtubule organising centre in the
cell, nucleating microtubules and anchoring a portion near to the
nucleus. Its role as a major component of the spindle poles is not
important in mature neurons, which do not divide. However, a
functioning, polarised microtubule network is still required for
intracellular trafficking in terminally differentiated cells such as
neurons and the centrosome is essential for maintaining this.
The inability of cells to migrate and the Golgi to re-orientate in the
scratch-wound assay provides a useful surrogate read-out for the
inability to repolarise the microtubule network in a desired
direction. In mature neurons, compromised cell polarity could
have severe long-term effects on neuronal function and survival. A
polarised microtubule network is essential for the rapid trafficking
of organelles and vesicles, especially those containing
neurotransmitters that need to be transported to synapses, and the
recycling of materials involved in neurotransmission. Diaz-Corrales
et al. also observed effects on intracellular transport of the dopamine
receptor, due to fragmentation of the Golgi (Diaz-Corrales et al.,
2012). Our data suggest that disruption of cell polarity could also
contribute to this impaired transport.
Our results show that aggresomes can prevent a cell from turning
its centrosome into a cilium. Proteasome inhibition is known to
inhibit ciliogenesis by preventing proteasomal degradation of
ciliogenesis inhibitory proteins such as trichoplein (Kasahara
et al., 2014). Our data, in which aggresomes are also generated by
α-syn overexpression, not just proteasome inhibition, point to the
aggresome inhibiting this process by itself. Whether this is a steric
Fig. 1. Aggresomes can be formed in cells by overexpression of alpha
synuclein or MG132 treatment. (A,A′) Vimentin (red) in control HeLa cells
forms a fibrous network around the nuclei (DAPI, blue), which is unaffected
by the expression of the GFP. (B,B′) When expressing GFP- α-syn,
vimentin-positive aggresomes appear in cells, juxtaposed to the nucleus.
Similar results are obtained with GFP-α-synA30P (C,C′) and GFP-α-
synA53T mutants (D,D′) and in SH-SY5Y cells treated in the same way
(E–H). (I–L) Aggresomes can also be induced by treatment with MG132.
(I,J) The vimentin distribution changes from a filamentous pattern around the
nuclei to caging the aggresome. (K,L) γ-tubulin (red) staining the
centrosomes as two punctae in control cells (K). Following MG132
treatment, γ-tubulin forms a condensed structure around the aggresome (L).
(M–P) The expression pattern of endogenous α-syn was also investigated to
determine whether this protein co-localises within the aggresome. (M,M′) In
control cells, endogenous α-syn (green) staining was widespread and
diffuse within the cytoplasm with vimentin (red) forming a filamentous
network. (N,N′) Following MG132 treatment, α-syn aggregates were
observed and co-localised with vimentin staining within the aggresomes.
(O,O′) In control cells, γ-tubulin (red) was observed as two punctae with
α-syn diffuse within the cytoplasm. (P,P′) γ-tubulin staining (red) also
co-localises with endogenous α-syn in the aggresome when treated with
MG132. (Q,Q′) Differentiated SH-SY5Y cells were mock-treated and
vimentin (red) staining was observed surrounding the nuclei as well as along
the axon. (R,R′) In cells treated with MG132 (1 μM for 18 h) vimentin
staining changed to a compact structure near the nucleus, indicative of
aggresomes. (S) In mock-treated cells, γ-tubulin formed two punctae next to
the nucleus. (T) In MG132 treated cells, aggresomes were detected by
γ-tubulin staining. Differentiated SH-SY5Y cells are TH positive (green).
(U,U′) In rat basal ganglion neurons, vimentin staining (red) is abundant
around the nuclei and along the axon. (V,V′) When treated with MG132,
vimentin localises to the aggresome. (W) In rat basal ganglion neurons, the
γ-tubulin is observed at two punctae close to the nucleus. (X) Upon
MG132 treatment, the γ-tubulin staining now forms a larger structure next to
the nucleus. (Y) In untreated RPE1-hTERT cells, γ-tubulin stains the
centrosome. (Z) Upon MG132 treatment it stains the aggresome. (α,β)
Similar results are obtained with MEFs. Scale bars: 10 μM. DNA/nuclei
stained with DAPI (blue) where indicated.
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Fig. 2. Microtubule nucleation is disrupted in the
presence of aggresomes in undifferentiated and
differentiated SH-SY5Y cells. (Ai–iv) SH-SY5Y cells have an
extensive microtubule network. Upon cold treatment (4°C,
t=0), microtubules depolymerise. Upon warming, microtubules
nucleate from the centrosome forming a characteristic aster,
which continues to grow until the network is re-established. In
SH-SY5Y cells the aster is seen within in 30 s (37°C, t+0.5)
and the microtubule network is re-established within 10 min
(37°C, t+10). (Av–viii) In the presence of aggresomes formed
by the overexpression of α-syn (GFP-fusion), the centrosome
is unable to re-establish the network in 10 min. (Aix–xvi) The
same result is achieved by overexpression of α-syn A30P
and A53T familial mutants. (Axvii–xx) In the presence of
aggresomes formed after MG132 treatment, the centrosome
is unable to nucleate microtubules to re-establish this
network. (Axxi–xxiv) In differentiated SH-SY5Y (tyrosine
hydroxylase, TH, in green), microtubule nucleation is seen as
asters from the centrosome (arrow heads and inset).
(Axxv–xxviii) In the presence of aggresomes the density of the
network is reduced and microtubule nucleation is severely
compromised. (B) Quantification of microtubule regrowth in
experiments in A [P=0.0001, one-way ANOVA (for α-syn over-
expression), 100 cells, n=3 replicates; P=0.0001, by Student’s
t-test (MG132 experiments), 100 cells, n=3 replicates].
Microtubule nucleation and re-establishment of this network
was quantified by scoring cells (yes or no) whether the
network was re-established in 10 min. Microtubule staining for
α-syn experiments shown separately in Fig. S1 together with
GFP control. Scale bars: 10 μM.
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effect or due to competitive inhibition of degradation of trichoplein
and similar molecules remains to be determined. In PD, this may be
relevant to those cells that undergo ciliogenesis. An early symptom
of PD is loss of smell and anosmia may precede other symptoms
(Doty et al., 1988; Haehner et al., 2007). It is not clear what the
cause of anosmia is, the assumption being that loss or impairment of
neurons processing olfactory information is the cause. An
alternative explanation is that the olfactory neurons themselves are
affected during PD progression. Olfactory neurons are part of the
dopaminergic system (Pignatelli and Belluzzi, 2017) and the
Fig. 3. Aggresomes reduce rate of cell migration and inhibit polarity
changes. (A–D) RPE1 cells close a scratch/wound in 8 h. (E–H) In the
presence of aggresomes, minimal cell migration is detected. (I-L) MEFs
close a scratch-wound assay in 8 h whereas those treated with MG132 to
induce aggresomes fail to do so (M–P). (Q,R) In control cells, the Golgi (red)
orientates from a random direction to face the leading edge of the wound.
(S,T) In the presence of aggresomes, this change in orientation was not
seen. (U,V) Quantification of change in angle of orientation during cell
migration with a schematic diagram showing how the Golgi orientation was
measured. (P=0.0011, by Student’s t-test, 100 cells, n=3 replicates). Scale
bars: 100 μM. Nuclei stained with DAPI (blue).
Fig. 4. See next page for legend.
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olfactory receptors are housed in cilia on these cells. If early in the
development of PD the ability of olfactory neurons to renew cilia
was compromised then the sense of smell would be affected as a
consequence. This hypothesis certainly warrants further
investigation as it may reveal that the olfactory cells are the
sentinels of the dopaminergic system and anosmia represents a first
indicator of dopaminergic cell dysfunction. While proving that
Lewy bodies affect microtubule nucleation and cellular polarity in
neurons of PD patients is likely to prove difficult, nasal brushing, a
method to sample olfactory neurons from the epithelium (Orru et al.,
2014), might offer a route to analyse the olfactory cilia. Indeed, this
process has been able to detect α-syn and other aggregating proteins
involved in neurodegenerative diseases in olfactory neurons from
patients (Brozzetti et al., 2020).
MATERIALS AND METHODS
Cell culture
Cell lines used include: HeLa, provided by Prof. George Dickson at Royal
Holloway; neuroblastoma cell line SH-SY5Y, provided by Prof. Robin
Williams at Royal Holloway; RPE1-hTERT, kindly provided by Prof. Erich
Nigg, Basel, Switzerland; MEFs, provided by Dr Jenny Murdoch at Royal
Holloway. Primary rat basal ganglion neurons were prepared by Dr Simona
Ursu at Royal Holloway.
HeLa and SH-SY5Y cells were maintained in Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 10% Foetal Bovine Serum
(FBS), 1x antibiotic-antimycotic mix (Gibco; 5000 units of penicillin,
5000 μg streptomycin and 15 μg Amphotericin B) and 2 mM L-glutamine.
RPE1-hTERT were grown in DMEM with nutrient mixture F-12 Ham
(DMEMF-12) supplemented with 10% FBS, 1× antibiotic-antimycotic (5000
units of penicillin, 5000 μg streptomycin and 15 μg Gibco Amphotericin B),
2 mM L-glutamine and 0.38% sodium bicarbonate. MEFs were grown in
DMEM supplemented with 10% FBS, 1× antibiotic-antimycotic, 2 mM
L-glutamine and 1x non-essential amino acids. All cell lines were cultured at
37°C in a humidified atmosphere with 5% CO2. The same media mix was
used for future experimental assays unless otherwise stated.
Primary basal ganglion neurons
Primary cultures of basal ganglion neurons were prepared from E18 Sprague
Dawley rat embryos as previously described (Marsh et al., 2017). Briefly,
cells were plated at a density of either 75,000 or 500,000 cells on poly-D-
lysine-coated (Sigma-Aldrich, 0.1 mg/ml in borate buffer pH 8.5) 22 mm2
glass cover slips. The plating medium was DMEM supplemented with 5%
FBS, penicillin/streptomycin and 0.5 mM L-glutamine (all from Invitrogen).
On the next day the medium was changed to full neurobasal medium
(neurobasal medium supplemented with B27, 0.5 mM L-glutamine, all from
Invitrogen). Cultures were incubated at 37°C and 5% CO2, and were used at
18 days in vitro.
SH-SY5Y differentiation
Cells were plated on collagen-coated coverslips in 12-well plates. Optimised
seeding density was calculated to be 6×104 cells in 12-well culture plates.
Cells were seeded out in DMEM serum supplemented media, The media
was replaced the following day with DMEM-F12 supplemented with 1%
FBS, 2 mM L-glutamine, 1× antimicrobial mix (5000 units of penicillin,
5000 μg streptomycin and 15 μg Gibco Amphotericin B), 1× non-essential
amino acids and 10 μM all trans-retinoic acid (RA). Every 2 days the media
was replenished and after 7 days differentiation was observed.
Aggresome formation
Aggresomes were induced by either treating cells with the proteasome
inhibitor MG132 (Sigma-Aldrich) or by overexpressing GFP-tagged
human α-syn. The optimal MG132 concentration was determined for
each cell line ranging from 1 μM to 10 μM (HeLa, 10 μM; SH-SY5Y,
1 μM; differentiated SH-SY5Y, 1 μM; and rat neurons, 3 μM). MG132
was added to media for 18 h at 37°C in a humidified atmosphere with
5% CO2.
Constructs including pEGFP-C2, pEGFP-αSYN, pEGFP-αSYNA30P
and pEGFP-αSYNA53T were transiently transfected into cells.
Lipofectamine 2000 (Thermo Fisher Scientific) was used as the
transfection reagent following the manufacturer’s instructions. In brief,
cells were plated onto glass coverslips in serum-supplemented media
without antibiotic-antimycotic mix. At 70% confluency cells were
transfected with DNA-lipid complexes (2.5 μg of plasmid DNA was
diluted in 250 µL Opti-MEM+10 μL of Lipofectamine 2000 reagent in
240 μL of Opti-MEM). Complexes were added to each well for 5 h at 37°C
after which the media was replaced by low serum-supplemented media
(DMEM, 1% FBS, 2 mM L-glutamine and 1% antibiotic-antimitotic mix
for HeLa and SH-SY5Y; DMEM-F12, 1% FBS, 1% antibiotic-antimitotic
mix for RPE1-hTERT). Overexpression was achieved at 72 h from the time
of transfection.
Microtubule re-growth assay
Cells were plated onto ethanol-washed glass coverslips in serum-
supplemented media. At 70% confluency the samples were processed for
the respective condition (MG132 treatment or overexpression of α-syn). The
plate was incubated on ice for 30 min then pre-warmed media (37°C) was
added. Samples were fixed at different time points ranging from 0.5 min to
25 min, depending on the cell line, including immediately after 30 min on
ice. Cells were fixed for 10 min with methanol (−20°C), washed with PBS
and stored in PBS.
Ciliogenesis assay
Cells were plated on glass coverslips in 6- or 12-well culture plates in serum-
supplemented media. Cells were treated with MG132 or transfected with
α-syn overexpression constructs to form aggresomes. The media was
replaced the following day with serum free media; samples were incubated
for 24 h to induce cilia formation. Cells were fixed using 4% (v/v)
formaldehyde (FA) for 10 min. FAwas aspirated and cells werewashed with
PBS. Samples were stored in 0.2% Triton in PBS until they were processed
for immunocytochemistry.
Cells migration assay (scratch-wound assay)
MEFs and RPE1-hTERTwere used in the wound assay. MEFs were plated
onto collagen-coated 35 mm plastic Petri dishes. At 100% confluency
(with or without aggresome formation using MG132) a P200 pipetman
tip was used to make wound. The media was aspirated and washed
twice with 1× PBS to remove detached cells. CO2 independent media
supplemented with 10% FBS, 2 mM L-glutamine, 1× antibiotic-
antimycotic mix was added for time-lapse experiments. Images were
taken using a Nikon TE300 microscope with a 37°C chamber, over a 24-h
period with images taken every 2 min. Similarly, RPE1-hTERT cells were
plated onto ethanol-washed glass coverslips and treated with MG132. Cell
migration was assessed by fixing cells at set time points with ice-cold
methanol.
Golgi orientation
A Golgi positioned within −45° and +45° of the wound was considered to
be orientated towards the wound. The average angle of orientation was
Fig. 4. Aggresomes inhibit ciliogenesis. All panels: DNA/nuclei stained with
DAPI (blue), green label is indicated in each panel, cilia (white arrows) can be
identified by acetylated tubulin (red). (A–F)When transfected with aGFP-α-syn
expression plasmid (α-syn and A30P and A53T familial mutants) or treated
with MG132, cilia formation is inhibited in undifferentiated SH-SH5Y cells
(B, C and D versus A, F versus E). In the presence of aggresomes
differentiated SH-SY5Y cells are no longer able to form cilia (H versus G).
When treated with MG132, TH-positive basal ganglion neurons are no longer
able to form cilia (J versus I). The acetylated tubulin signal (red) in J and I is
overexposed to ensure no cilia weremissed. (K) Quantification of ciliation: GFP
expressing versus GFP-α-syn expression, (P=0.0003, by one-way ANOVA,
100 cells, n=3); undifferentiated SH-SY5Y, untreated versus MG132,
(P=0.0001, by Student’s t-test, 100 cell, n=3); differentiated SH-SY5Y,
untreated versus MG132, (P=0.0001 by Student’s t-test, 100 cells counted,
n=3). Scale bars: 10 μM.
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calculated using the formula (Σ√α2)/n where α is the angle between the
Golgi and a line perpendicular to the wound edge.
Immunocytochemistry
Cells were fixed with either methanol (−20°C) or 4% (v/v) FA for 10 min.
The fixative was removed and washed with PBS (3×5 min). Cells were
blocked in 3% BSA for 30 min at room temperature. Cells were incubated
with primary antibody in 1% BSA, either for 3 h at room temperature on a
shaking platform or overnight at 4°C on a shaking platform. After primary
antibody incubation the cells were washed with PBS (3×5 min) and
incubated with secondary antibody for 1 h at room temperature on a shaking
platform. Cells were washed with PBS (3×5 min) and mounted using
FluorSave (Calbiochem). Primary antibodies used were: rabbit anti-
Tyrosine Hydroxylase (Merck-Millipore), 0.1 μg/ml; mouse anti-vimentin
(Sigma-Aldrich), 1 μg/ml; mouse anti-acetylated-tubulin (Invitrogen) 1 μg/
ml; mouse anti-γ-tubulin (Sigma-Aldrich), 1 μg/ml; rabbit anti-γ-tubulin
(Sigma-Aldrich), 1 μg/m; mouse anti-α-tubulin (Sigma-Aldrich), 1 μg/ml;
rabbit anti-α-syn (Cell Signaling Technology), 10 μg/ml; mouse anti-Golgin
97 (Thermo Fisher Scientific), 1 μg/ml. Secondary antibodies used were:
goat anti-mouse IgG, Alexa Fluor 594-conjugated (Invitrogen) 1 μg/ml; goat
anti-mouse IgG, Alexa Fluor 488-conjugated (Invitrogen) 1 μg/ml; and goat
anti-rabbit IgG Alexa Fluor 488-conjugated (Invitrogen) 1 μg/ml. Images
were taken using a Nikon Ni-E fluorescence microscope.
Wholemount immunostaining
Embryos were fixed with Dent’s fixative (80:20, methanol: DMSO) or 4%
(v/v) FA overnight at 4°C. Fixativewas removed the following day; embryos
fixed with Dent’s fixative were stored in methanol at −20°C; FA fixed
Fig. 5. Olfactory cilia in zebrafish larvae are severely reduced in the presence of aggresomes. (A) The neuronal dopaminergic network in
3 dpf zebrafish forebrain viewed from the dorsal aspect, detected by TH-staining (green). Acetylated tubulin (red) stains axon tracts and cilia.
(B–E) Overexpression of control GFP or α-syn, α-synA30P, α-synA53T familial mutations does not cause any anatomical defects in zebrafish larvae.
(F) By 3 dpf extensive numbers of cilia are visible at the olfactory pit. (G–I) Overexpression of any of the three forms of α-syn (wild type, A30P or A53T)
severely reduces numbers of cilia in the olfactory pit. Cilia length is also reduced. (J,K) Embryos treated with MG132 showed an extensive reduction in
number of cilia. (L) Quantification of cilia numbers from above experiments (P=0.001, by one-way ANOVA, n=3). Cilia were counted from the confocal
generated z-stacks, projected images of which are shown in this figure. (M) Quantification of length of cilia from F-I (P=0.0088, by one-way ANOVA, n=3).
Scale bars: 100 μM.
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embryos were stored in PBS +0.2% Triton. Embryos fixed with Dent’s
fixative were permeabilised by incubation in 100% methanol for 30 min at
−20°C. Embryos were rehydrated by washing in serial dilution of methanol
in PBS including: MeOH:PBS at 70:30, 50:50 and 30:70 and final wash
with PBS. FA fixed embryos were permeabilised by incubation in 0.25%
trypsin-EDTA in PBS for 10 min on ice and then washed three times for
30 min in PBS +0.02% Triton. Embryos were blocked for 4 h in 10% heat-
inactivated goat serum, 1% bovine serum albumin and 0.2% Triton in PBS.
Embryos were incubated with primary and secondary antibodies for 36 h in
blocking solution. Primary antibodies used: rabbit anti-Tyrosine Hydroxylase
(MERKMillipore), 0.1 μg/ml; and mouse anti-acetylated-tubulin (Invitrogen)
1 μg/ml. Secondary antibodies used were goat anti-mouse IgG, Alexa Fluor
594-conjugated (Invitrogen) 1 μg/ml; and goat anti-rabbit IgG Alexa Fluor
488-conjugated (Invitrogen) 1 μg/ml. Confocal stacks were imaged with an
Olympus FX81/FV1000 laser confocal system using Ar gas laser and He-Ne
diode laser. Stacks were taken in 1 μM thickness and are represented as
maximum-intensity projections. Stacks were analysed using ImageJ.
mRNA synthesis
mRNAs were transcribed from the Sp6 promoter of the pCS2+-based
plasmids encoding α-syn andmutant forms, using the mMessage mMachine
in vitro transcription kit (Ambion, TX, USA). RNA was purified using the
Qiagen RNeasy kit (Qiagen).
Zebrafish
Zebrafish were maintained and bred at 26.5°C; embryos were raised at 28.5°C.
Both AB and TL wild-type strains were used for these studies. Embryos
were processed by 33 dpf. No protected species, as defined by the Animals
(Scientific Procedures) Act, 1986 were used for experiments in this study.
Embryos were injected into the yolk with mRNA using a micromanipulator-
mounted micropipette (Borosil 1.0×0.5 mm, Frederick Haer & Co., Inc., USA)
and a Picospritzer microinjector. Between 150–200 pg of mRNAwas injected
into the yolk of the embryos at 1–4 cell stage. For MG132 treatment, embryos
were treated with 50 μM for 48 h. Embryos processed for immunostaining were
grown in 0.003% phenylthiourea to inhibit melanin production.
Statistics
Statistical tests used for each experiment are given in the figure legends.
t-tests were used when comparing two treatments and ANOVA for multiple
treatments. n numbers represent the experimental unit, either number of
embryos or separate cell culture experiments. Error bars show the standard
deviation. Analysis performed using GraphPad Prism v8.
Animal studies
No protected stages of zebrafish, as defined by the Animals (Scientific
Procedures) Act 1986, were used for experiments in this study, only fry less
than 5 dpf. Rats were killed by Schedule 1 methods, according to Home
Office regulations, in compliance with the Animals (Scientific Procedures)
Act 1986.
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